Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone Taper Following Total Knee Arthroplasty
NCT06489626Phase 4Withdrawn
- Start
- Nov 2025
- Primary completion
- Oct 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone in postoperative pain. Planned start Nov 2025; status: withdrawn.
02
Drugs
methylprednisolone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06489626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06489626.